Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Fuse

Showing results (191-200 of 222) with videos related to

Pageof 23
Sort By:
Journal of Dairy Science|October 1, 1996
Effect of growth hormone-releasing factor on the response to insulin of cows during early and late lactationM T Rose, Y Obara, H Fuse, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 1, 1997
A new synthetic steroid, osaterone acetate (TZP-4238), increases cortical bone mass and strength by enhancing bone formation in ovariectomized ratsH Fuse, S Fukumoto, H Sone, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 1, 1986
[Two cases of "9 + 0" immotile spermatozoa]H Sumiya, M Takahara, Z Kataumi, et al.
Molecular and Cellular Biology|January 16, 1999
Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analogK Takeyama, Y Masuhiro, H Fuse, et al.
International Urology and Nephrology|January 1, 1990
Plasma concentration of atrial natriuretic factor in idiopathic oedemaT Nakada, J Shimazaki, S Isaka, et al.
Hinyokika Kiyo. Acta Urologica Japonica|August 11, 2001
[Primary small cell carcinoma of the kidney: a case report]T Miyagi, H Fuse, M Takashima, et al.
Hinyokika Kiyo. Acta Urologica Japonica|March 1, 1990
[Clinical studies on endocrine therapy of prostatic carcinoma (2): Prognosis of patients with prostatic carcinoma given endocrine therapy, and analyses of causes of death and side effects of endocrine therapy]Y Kumamoto, T Tsukamoto, T Umehara, et al.
Hinyokika Kiyo. Acta Urologica Japonica|November 1, 1990
[Clinical phase I and phase II study on a sustained release formulation of leuprorelin acetate (TAP-144-SR), an LH-RH agonist, in patients with prostatic carcinoma. Collaborative++ Studies on Prostatic Carcinoma by the Study Group for TAP-144-SR]T Niijima, Y Aso, H Akaza, et al.
The Journal of International Medical Research|January 1, 1990
Leuprorelin acetate depot: results of a multicentre Japanese trial. TAP-144-SR Study GroupH Akaza, Y Aso, K Koiso, et al.
Hinyokika Kiyo. Acta Urologica Japonica|September 1, 1987
[The evaluation of chemotherapy of relapse in prostatic cancer with new response criteria]S Isaka, H Fuse, H Akaza, et al.
Pageof 23

Showing results (191-200 of 222) with videos related to

Sort By:
Pageof 23
Journal of Dairy Science|October 1, 1996
Effect of growth hormone-releasing factor on the response to insulin of cows during early and late lactationM T Rose, Y Obara, H Fuse, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 1, 1997
A new synthetic steroid, osaterone acetate (TZP-4238), increases cortical bone mass and strength by enhancing bone formation in ovariectomized ratsH Fuse, S Fukumoto, H Sone, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 1, 1986
[Two cases of "9 + 0" immotile spermatozoa]H Sumiya, M Takahara, Z Kataumi, et al.
Molecular and Cellular Biology|January 16, 1999
Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analogK Takeyama, Y Masuhiro, H Fuse, et al.
International Urology and Nephrology|January 1, 1990
Plasma concentration of atrial natriuretic factor in idiopathic oedemaT Nakada, J Shimazaki, S Isaka, et al.
Hinyokika Kiyo. Acta Urologica Japonica|August 11, 2001
[Primary small cell carcinoma of the kidney: a case report]T Miyagi, H Fuse, M Takashima, et al.
Hinyokika Kiyo. Acta Urologica Japonica|March 1, 1990
[Clinical studies on endocrine therapy of prostatic carcinoma (2): Prognosis of patients with prostatic carcinoma given endocrine therapy, and analyses of causes of death and side effects of endocrine therapy]Y Kumamoto, T Tsukamoto, T Umehara, et al.
Hinyokika Kiyo. Acta Urologica Japonica|November 1, 1990
[Clinical phase I and phase II study on a sustained release formulation of leuprorelin acetate (TAP-144-SR), an LH-RH agonist, in patients with prostatic carcinoma. Collaborative++ Studies on Prostatic Carcinoma by the Study Group for TAP-144-SR]T Niijima, Y Aso, H Akaza, et al.
The Journal of International Medical Research|January 1, 1990
Leuprorelin acetate depot: results of a multicentre Japanese trial. TAP-144-SR Study GroupH Akaza, Y Aso, K Koiso, et al.
Hinyokika Kiyo. Acta Urologica Japonica|September 1, 1987
[The evaluation of chemotherapy of relapse in prostatic cancer with new response criteria]S Isaka, H Fuse, H Akaza, et al.
Pageof 23